These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 34725727

  • 21. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and 68 Ga-PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node dissection for prostate cancer.
    Franklin A, Yaxley WJ, Raveenthiran S, Coughlin G, Gianduzzo T, Kua B, McEwan L, Wong D, Delahunt B, Egevad L, Samaratunga H, Brown N, Parkinson R, Roberts MJ, Yaxley JW.
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [Abstract] [Full Text] [Related]

  • 22. Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer.
    Eiber M, Weirich G, Holzapfel K, Souvatzoglou M, Haller B, Rauscher I, Beer AJ, Wester HJ, Gschwend J, Schwaiger M, Maurer T.
    Eur Urol; 2016 Nov; 70(5):829-836. PubMed ID: 26795686
    [Abstract] [Full Text] [Related]

  • 23. Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer.
    Touijer KA, Michaud L, Alvarez HAV, Gopalan A, Kossatz S, Gonen M, Beattie B, Sandler I, Lyaschenko S, Eastham JA, Scardino PT, Hricak H, Weber WA.
    Eur Urol Oncol; 2019 Mar; 2(2):166-173. PubMed ID: 31017093
    [Abstract] [Full Text] [Related]

  • 24. A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI.
    Porpiglia F, Checcucci E, DE Cillis S, Piramide F, Amparore D, Piana A, Volpi G, Granato S, Zamengo D, Stura I, Alladio E, Migliaretti G, DE Luca S, Bollito E, Gned D, DI Dio M, Autorino R, Manfredi M, Fiori C.
    Minerva Urol Nephrol; 2023 Feb; 75(1):31-41. PubMed ID: 36626117
    [Abstract] [Full Text] [Related]

  • 25. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
    Tran V, Hong A, Sutherland T, Taubman K, Lee SF, Lenaghan D, Sethi K, Corcoran NM, Lawrentschuk N, Woo H, Tarlinton L, Bolton D, Spelman T, Thomas L, Booth R, Hegarty J, Perry E, Wong LM.
    BMJ Open; 2022 Sep 19; 12(9):e061815. PubMed ID: 36123093
    [Abstract] [Full Text] [Related]

  • 26. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M, Montgomery J, Kunju LP, Siddiqui J, Rogers V, Rajendiran T, Johnson TD, Shao X, Davenport MS.
    J Nucl Med; 2016 Jul 19; 57(7):1065-70. PubMed ID: 26985061
    [Abstract] [Full Text] [Related]

  • 27. Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study.
    Qiu DX, Li J, Zhang JW, Chen MF, Gao XM, Tang YX, Zhang Y, Yi XP, Yin HL, Gan Y, Wang GL, Zu XB, Hu S, Cai Y.
    Eur J Nucl Med Mol Imaging; 2022 Jul 19; 49(8):2821-2832. PubMed ID: 34860277
    [Abstract] [Full Text] [Related]

  • 28. Targeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer.
    Pepe P, Pepe L, Tamburo M, Marletta G, Pennisi M, Fraggetta F.
    Arch Ital Urol Androl; 2022 Sep 26; 94(3):274-277. PubMed ID: 36165469
    [Abstract] [Full Text] [Related]

  • 29. The PRIMARY Score: Using Intraprostatic 68Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis.
    Emmett L, Papa N, Buteau J, Ho B, Liu V, Roberts M, Thompson J, Moon D, Sheehan-Dare G, Alghazo O, Agrawal S, Murphy D, Stricker P, Hope TA, Hofman MS.
    J Nucl Med; 2022 Nov 26; 63(11):1644-1650. PubMed ID: 35301240
    [Abstract] [Full Text] [Related]

  • 30. Combination of MRI prostate and 18F-DCFPyl PSMA PET/CT detects all clinically significant prostate cancers in treatment-naive patients: An international multicentre retrospective study.
    Parathithasan N, Perry E, Taubman K, Hegarty J, Talwar A, Wong LM, Sutherland T.
    J Med Imaging Radiat Oncol; 2022 Oct 26; 66(7):927-935. PubMed ID: 35170858
    [Abstract] [Full Text] [Related]

  • 31. Incremental Impact of [68 Ga]Ga-PSMA-11 PET/CT in Primary N and M Staging of Prostate Cancer Prior to Curative-Intent Surgery: a Prospective Clinical Trial in Comparison with mpMRI.
    Szigeti F, Schweighofer-Zwink G, Meissnitzer M, Hauser-Kronberger C, Hitzl W, Kunit T, Forstner R, Pirich C, Beheshti M.
    Mol Imaging Biol; 2022 Feb 26; 24(1):50-59. PubMed ID: 34519966
    [Abstract] [Full Text] [Related]

  • 32. Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.
    Zamboglou C, Drendel V, Jilg CA, Rischke HC, Beck TI, Schultze-Seemann W, Krauss T, Mix M, Schiller F, Wetterauer U, Werner M, Langer M, Bock M, Meyer PT, Grosu AL.
    Theranostics; 2017 Feb 26; 7(1):228-237. PubMed ID: 28042330
    [Abstract] [Full Text] [Related]

  • 33. Detection of clinically significant prostate cancer with 18F-DCFPyL PET/multiparametric MR.
    Metser U, Ortega C, Perlis N, Lechtman E, Berlin A, Anconina R, Eshet Y, Chan R, Veit-Haibach P, van der Kwast TH, Liu A, Ghai S.
    Eur J Nucl Med Mol Imaging; 2021 Oct 26; 48(11):3702-3711. PubMed ID: 33846845
    [Abstract] [Full Text] [Related]

  • 34. 18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 1. Improved Risk Stratification for MRI-Guided Transrectal Prostate Biopsies.
    Davenport MS, Montgomery JS, Kunju LP, Siddiqui J, Shankar PR, Rajendiran T, Shao X, Lee E, Denton B, Barnett C, Piert M.
    J Nucl Med; 2020 Mar 26; 61(3):337-343. PubMed ID: 31420496
    [Abstract] [Full Text] [Related]

  • 35. Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging Trial.
    Sonni I, Felker ER, Lenis AT, Sisk AE, Bahri S, Allen-Auerbach M, Armstrong WR, Suvannarerg V, Tubtawee T, Grogan T, Elashoff D, Eiber M, Raman SS, Czernin J, Reiter RE, Calais J.
    J Nucl Med; 2022 Jun 26; 63(6):847-854. PubMed ID: 34649942
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic accuracy of 68 Ga-PSMA PET/MRI and multiparametric MRI in detecting index tumours in radical prostatectomy specimen.
    Coşar U, Şen İ, Aydos U, Koparal MY, Uçar M, Tokgöz N, Gönül İI, Akdemir ÜÖ, Atay LÖ, Sözen TS.
    Int J Clin Pract; 2021 Aug 26; 75(8):e14287. PubMed ID: 33931929
    [Abstract] [Full Text] [Related]

  • 37. 68Ga-PSMA-PET/CT in addition to mpMRI in men undergoing biopsy during active surveillance for low- to intermediate-risk prostate cancer: study protocol for a prospective cross-sectional study.
    Gondoputro W, Doan P, Katelaris A, Scheltema MJ, Geboers B, Agrawal S, Liu Z, Yaxley J, Savdie R, Rasiah K, Frydenberg M, Roberts MJ, Malouf D, Wong D, Shnier R, Delprado W, Emmett L, Stricker PD, Thompson J.
    Transl Androl Urol; 2023 Oct 31; 12(10):1598-1606. PubMed ID: 37969779
    [Abstract] [Full Text] [Related]

  • 38. Multiparametric Magnetic Resonance Imaging of the Prostate and Prostate-specific Membrane Positron Emission Tomography Prior to Prostate Biopsy (MP4 Study).
    Woo HH, Khanani H, Thompson NJ, Sorensen BJ, Baskaranathan S, Bergersen P, Chalasani V, Dean T, Dias M, Symons J, Wines M, Jain A, Nassour AJ, Tarlinton LC.
    Eur Urol Open Sci; 2023 Jan 31; 47():119-125. PubMed ID: 36601041
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
    Kawada T, Yanagisawa T, Rajwa P, Sari Motlagh R, Mostafaei H, Quhal F, Laukhtina E, Aydh A, König F, Pallauf M, Pradere B, Ceci F, Baltzer PAT, Hacker M, Rasul S, Karakiewicz PI, Araki M, Nasu Y, Shariat SF.
    Eur Urol Oncol; 2022 Aug 31; 5(4):390-400. PubMed ID: 35715320
    [Abstract] [Full Text] [Related]

  • 40. Findings in 1,123 Men with Preoperative 68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computerized Tomography and Multiparametric Magnetic Resonance Imaging Compared to Totally Embedded Radical Prostatectomy Histopathology: Implications for the Diagnosis and Management of Prostate Cancer.
    Raveenthiran S, Yaxley WJ, Franklin T, Coughlin G, Roberts M, Gianduzzo T, Kua B, Samaratunga H, Delahunt B, Egevad L, Wong D, McEwan L, Brown N, Parkinson R, Esler R, Yaxley JW.
    J Urol; 2022 Mar 31; 207(3):573-580. PubMed ID: 34694140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.